Detailed Information for C00704

Basic information about inhibitors

IPAD-DB ID C00704
Name Myricetin
Category Natural compounds
2D Structure
3D Structure
Molecular Formula C 1 5 H 1 0 O 8
Molecular Weight 318.23g/mol
IUPAC Name 3, 5, 7-trihydroxy-2-(3, 4, 5-trihydroxyphenyl)chromen-4-one
InChI InChI=1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4, 16-20, 22H
InChIKey IKMDFBPHZNJCSN-UHFFFAOYSA-N
Canonical SMILES C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O
PubChem CID 5281672
DrugBank Accession Number -
CAS Registry Number 529-44-2

Biological activity data

Ki -
EC50 -
IC50 -
Inhibition Less than 40%
Toxicity -
ROS(reactive oxygen species) -
Metal Chelating -
BBB(blood-brain barrier) -
Target Protein Aβ1-42
Effects (1) Myricetin can inhibit the Aβ aggregation pathway from Aβ monomers to A11-positive oligomers, accelerating the pathway from A11-positive oligomers to Aβ deposition,
Research Models Tg2576 AD mouse
Main Source -
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 318.24
Hac(Computed by SwissADME) 23
Volume(Computed by ADMETlab 2.0) 291.557
Density(Computed by ADMETlab 2.0) 1.091
nRing(Computed by ADMETlab 2.0) 3
MaxRing(Computed by ADMETlab 2.0) 10
nHet(Computed by ADMETlab 2.0) 8
fChar(Computed by ADMETlab 2.0) 0
nRig(Computed by ADMETlab 2.0) 18
Flexibility(Computed by ADMETlab 2.0) 0.056
Stero Centers(Computed by ADMETlab 2.0) 0
LogS(Computed by ADMETlab 2.0) -3.665
LogD(Computed by ADMETlab 2.0) 0.9

ADMET properties

logP(Computed by ADMETlab 2.0) 1.69
TPSA(Computed by SwissADME) 151.59 Ų
Hbond Acceptor(Computed by SwissADME) 8
Hbond Donor(Computed by SwissADME) 6
Rotatable Bonds(Computed by SwissADME) 1

Pharmacokinetics

GI Absorption(Computed by SwissADME) Low
BBB(blood-brain barrier) Permeant(Computed by SwissADME) No
P-gp Substrate(Computed by SwissADME) No
CYP1A2 Inhibitor(Computed by SwissADME) Yes
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) No
CYP2D6 Inhibitor(Computed by SwissADME) No
CYP3A4 Inhibitor(Computed by SwissADME) Yes
log Kp(Skin Permeation)(Computed by SwissADME) -7.40 cm/s

Druglikeness

Lipinski(Computed by SwissADME) Yes, 1 violation: NHorOH>5
Ghose(Computed by SwissADME) Yes
Veber(Computed by SwissADME) No, 1 violation: TPSA>140
Egan(Computed by SwissADME) No, 1 violation: TPSA>131.6
Muegge(Computed by SwissADME) No, 2 violations: TPSA>150, H-don>5
Bioavailability Score(Computed by SwissADME) 0.55